Journal article 636 views
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways
Hiu-Fung Yuen,
Ka-Kui Chan,
Claire Grills,
James Murray ,
Angela Platt-Higgins,
Osama Sharaf Eldin,
Ken O'Byrne,
Pasi Janne,
Dean A. Fennell,
Patrick G. Johnston,
Philip S. Rudland,
Mohamed El-Tanani
Clinical Cancer Research, Volume: 18, Issue: 2, Pages: 380 - 391
Swansea University Author: James Murray
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1158/1078-0432.ccr-11-2035
Abstract
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways
Published in: | Clinical Cancer Research |
---|---|
ISSN: | 1078-0432 1557-3265 |
Published: |
American Association for Cancer Research (AACR)
2012
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa56416 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
College: |
Faculty of Medicine, Health and Life Sciences |
---|---|
Issue: |
2 |
Start Page: |
380 |
End Page: |
391 |